Cushing syndrome is caused by long-term exposure to high cortisol levels. Diagnosing the cause can help determine the type of treatment needed. Lifestyle changes can also help with symptoms. Every ...
Recordati Rare Diseases Canada Inc. announced today the Canadian product availability of ISTURISA® (osilodrostat) for the treatment of adult patients with Cushing's disease who have persistent or ...
Expert Rev Endocrinol Metab. 2013;8(2):183-193. Mitotane reduces cortisol synthesis through the inhibition of 11B-hydroxylase, 18-hydroxylase, 3-α hydroxylase, hydroxysteroid dehydrogenase and several ...
If you have high blood sugar from Cushing’s syndrome, you know how challenging it can be to control. Surgery can sometimes cure the condition, but it is not always successful or possible for everyone.
-- Leading Cushing's disease companies developing emerging therapies, such as Corcept Therapeutics, Sparrow Pharmaceuticals, Crinetics Pharmaceuticals, H. Lundbeck, Stero Therapeutics, and others, are ...
Cushing's syndrome and its pituitary variant, Cushing's disease, represent complex endocrine disorders characterised by chronic excessive glucocorticoid exposure. This hypercortisolaemia may be the ...
Cushing's syndrome is a complex endocrine disorder resulting from chronic hypercortisolism, which may arise from endogenous or exogenous sources. One of the most challenging diagnostic dilemmas in ...
The company was seeking approval for relacorilant as a treatment for patients with hypertension secondary to hypercortisolism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback